Invesco’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$519K Buy
2025
Q1
$407K Buy
2024
Q4
$458K Sell
2024
Q3
$4.05M Buy
2024
Q2
$385K Sell
2024
Q1
$5.79M Buy
2022
Q2
Sell
2022
Q1
$29K Buy
2021
Q4
$58K Sell
2021
Q3
$117K Buy
2021
Q2
$90K Buy
2020
Q3
Sell
2020
Q2
$580K Buy
2018
Q4
Sell
2018
Q3
$252K Sell
2018
Q2
$382K Buy